Vaccines Articles
The U.S. Food and Drug Administration (FDA) has approved PharmaJet Inc.’s Stratis 0.5mL Needle-Free Jet Injector for delivery of bioCSL Inc.’s AFLURIA influenza vaccine for individuals ages 18 to 64 years.
The National Institutes of Health began human testing of an ebola vaccine in a Phase I clinical trial in September.
The Centers for Disease Control and Prevention found that vaccination coverage among adolescents ages 13 to 17 years rose between 2012 and 2013.
According to the U.S. Centers for Disease Control and Prevention, adult vaccination coverage remains well below Healthy People 2020 targets.
Update on HIV/AIDS, meningococcal Group B, tetanus, diphtheria, pertussis and dengue vaccines.
A recent study shows that a vaccine typically used to prevent tuberculosis in countries outside of the U.S. could also prevent multiple sclerosis (MS) in people who are in the beginning stages of the disease.
The Advisory Committee on Immunization Practices (ACIP) approved the Recommended Immunization Schedule for Adults Aged 19 Years or Older for 2014.
New research shows that women have a stronger immune response than men when given the flu vaccine, which may mean vaccinated women are better protected against catching the flu than vaccinated men.
Updates on clinical trials for vaccines against a protein believed to cause Alzheimer's, clostridium difficile and RSV.
A new study conducted by the Centers for Disease Control and Prevention shows that the number of childhood vaccines administered, either in a single day or during the first two years of life, has no bearing on autism risk.
A Canadian study showed that pregnant women who are vaccinated against the flu are significantly less likely to deliver premature or low-birth-weight babies compared with unvaccinated expectant mothers.
A new international study has found that vaccines may prevent the risk of strokes in children.